Abbott Laboratories Company Profile – Overview

Abbott Laboratories (Abbott) discovers, develops, manufactures and sells a diversified range of healthcare products including branded generic pharmaceuticals, diagnostic systems and tests, and pediatric and adult nutritional products. The company also offers various medical devices including heart failure, electrophysiology, rhythm management, vascular and structural heart devices, and neuromodulation devices. The company also offers minerals and nutrition products and dietary supplements. It has research and development facilities in the US, China, Colombia, India, Singapore, Spain, and the UK; and operates manufacturing facilities across the world. The company markets products in North America, Latin America, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Gain a 360-degree view of Abbott Laboratories and make more informed decisions for your business

Gain a 360-degree view of Abbott Laboratories and make more informed decisions for your business

Headquarters

United States of America

Address

100 Abbott Park Rd, Illinois, 60064-3500

Website


www.abbott.com

Telephone

1 224 6676100

No of Employees

115,000

Industry

Medical Equipment

Ticker Symbol & Exchange

ABT (NYSE)

Revenue (2023)

$43.7B


1.3%

EPS

XYZ

Net Income (2023)

XYZ


-2%

Market Cap*

$190.3B

Net Profit Margin (2023)

XYZ


-3.3%

* As of and is in US$

Gain access to our premium signals and make informed decisions for your business

Gain access to our premium signals and make informed decisions for your business

Abbott Laboratories premium industry data and analytics

1,200

+

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

750

+

A database of medical devices currently for sale around the world. Devices that have been approved by a regulatory authority are included.

130

+

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

970

+

Determine Abbott Laboratories go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

640

+

Understand Abbott Laboratories’s commercialized product portfolio to stay one step ahead of the market.

510

+

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

130

+

Identify which of Abbott Laboratories’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

130

+

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

70

+

Proactively evaluate Abbott Laboratories’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

60

+

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Abbott Laboratories’s relevant decision makers and contact details.

2

Track drug and patent expiries along with geographies impacted.

2

Review investigator profiles and find information on trial contacts across Abbott Laboratories, including performance indicators like number of completed trials, and linked attributes such as rehiring statistics.

1

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Abbott Laboratories (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

IT Client Prospector provides intelligence on Abbott Laboratories’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products
Brands


Established Pharmaceutical
Acculink

Gastroenterology Products
FreeStyle

XYZ
XYZ

XYZ
XYZ

XYZ
XYZ

Understand Abbott Laboratories portfolio and identify potential areas for collaboration

Understand Abbott Laboratories portfolio and identify potential areas for collaboration

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year
Event
Description

2023
Regulatory Approval
In April, the company announced two new clearances from the U.S. Food and Drug Administration (FDA) for the company’s industry-leading life support system.

2023
Contracts/Agreements
In April, the company entered into a partnership with the Climate Amplified Disease and Epidemics consortium to predict, track and control diseases that may be amplified by climate change.

2023
Regulatory Approval
In March, the company secured an approval from the U.S. Food and Drug Administration for Epic Max stented tissue valve to treat people with aortic regurgitation or stenosis.

Dive into past operations, including product releases, deals, acquisitions & more

Dive into past operations, including product releases, deals, acquisitions & more

Image for loader

Competitor Comparison

Key Parameters
Abbott Laboratories
F. Hoffmann-La Roche Ltd
GSK plc
Medtronic Plc
Eli Lilly and Co

Headquarters
United States of America
Switzerland
United Kingdom
Ireland
United States of America

City
Abbott Park
Basel
Brentford
Dublin
Indianapolis

State/Province
Illinois



Indiana

No. of Employees
115,000
103,613
69,400
95,000
39,000

Entity Type
Public
Public
Public
Public
Public

Benchmark the company against the market with exclusive information on key competitors

Benchmark the company against the market with exclusive information on key competitors

Chart Financial activity with access to more key stats

Chart Financial activity with access to more key stats

Executives

Name
Position
Board
Since
Age

Robert B. Ford

Chief Executive Officer; Chairman

Executive Board
2021
49

Robert E. Funck, Jr.

Executive Vice President – Finance; Chief Financial Officer

Senior Management
2020
61

Hubert L. Allen

General Counsel; Secretary; Executive Vice President

Senior Management
2013
57

Daniel Salvadori

Group President- Established Pharmaceuticals and Nutritional Products; Executive Vice President

Senior Management
2021
44

Michael D. Dale

Senior Vice President – Structural Heart

Senior Management
2019
63

Non Dignissim Eros
Proin vel
Convallis
2023
XY

Non Dignissim Eros
Proin vel
Convallis
2023
XY

Non Dignissim Eros
Proin vel
Convallis
2023
XY

Gain insight into Abbott Laboratories key executives to enhance your sales strategy

Gain insight into Abbott Laboratories key executives to enhance your sales strategy